Connection

Mitzi Nagarkatti to Interleukin-2

This is a "connection" page, showing publications Mitzi Nagarkatti has written about Interleukin-2.
Connection Strength

1.912
  1. Resveratrol prevents endothelial cells injury in high-dose interleukin-2 therapy against melanoma. PLoS One. 2012; 7(4):e35650.
    View in: PubMed
    Score: 0.371
  2. Blockade of hyaluronan inhibits IL-2-induced vascular leak syndrome and maintains effectiveness of IL-2 treatment for metastatic melanoma. J Immunol. 2007 Sep 15; 179(6):3715-23.
    View in: PubMed
    Score: 0.270
  3. Role of CD4(+)CD25(+) T regulatory cells in IL-2-induced vascular leak. Int Immunol. 2006 Oct; 18(10):1461-71.
    View in: PubMed
    Score: 0.251
  4. Role of spontaneous and interleukin-2-induced natural killer cell activity in the cytotoxicity and rejection of Fas+ and Fas- tumor cells. Blood. 1998 Dec 01; 92(11):4248-55.
    View in: PubMed
    Score: 0.147
  5. Evidence for the participation of interleukin-2 (IL-2) and IL-4 in the regulation of autonomous growth and tumorigenesis of transformed cells of lymphoid origin. Blood. 1997 Jan 15; 89(2):610-20.
    View in: PubMed
    Score: 0.129
  6. Constitutive activation of the interleukin 2 gene in the induction of spontaneous in vitro transformation and tumorigenicity of T cells. Proc Natl Acad Sci U S A. 1994 Aug 02; 91(16):7638-42.
    View in: PubMed
    Score: 0.109
  7. The role of IL-2 in the activation and expansion of regulatory T-cells and the development of experimental autoimmune encephalomyelitis. Immunobiology. 2013 Apr; 218(4):674-82.
    View in: PubMed
    Score: 0.095
  8. Characterization of T-cell memory phenotype after in vitro expansion of tumor-infiltrating lymphocytes from melanoma patients. Anticancer Res. 2011 Dec; 31(12):4099-109.
    View in: PubMed
    Score: 0.090
  9. Role of IL-2, IL-4 and IL-6 in the growth and differentiation of tumor-specific CD4+ T helper and CD8+ T cytotoxic cells. Int J Cancer. 1990 Jun 15; 45(6):1096-104.
    View in: PubMed
    Score: 0.082
  10. CD44 mobilization in allogeneic dendritic cell-T cell immunological synapse plays a key role in T cell activation. J Leukoc Biol. 2008 Jul; 84(1):134-42.
    View in: PubMed
    Score: 0.070
  11. Combined deficiency in CD44 and Fas leads to exacerbation of lymphoproliferative and autoimmune disease. Int Immunol. 2003 Nov; 15(11):1327-40.
    View in: PubMed
    Score: 0.052
  12. Targeted deletion of CD44v7 exon leads to decreased endothelial cell injury but not tumor cell killing mediated by interleukin-2-activated cytolytic lymphocytes. J Biol Chem. 2003 Oct 31; 278(44):43818-30.
    View in: PubMed
    Score: 0.051
  13. CD44-deficient mice exhibit enhanced hepatitis after concanavalin A injection: evidence for involvement of CD44 in activation-induced cell death. J Immunol. 2001 May 15; 166(10):5889-97.
    View in: PubMed
    Score: 0.044
  14. Double-negative T cells from MRL-lpr/lpr mice mediate cytolytic activity when triggered through adhesion molecules and constitutively express perforin gene. J Exp Med. 1993 Dec 01; 178(6):2225-30.
    View in: PubMed
    Score: 0.026
  15. Murine lymphocytes exhibit heterogeneity in their proliferative responsiveness to calcium ionophore. Cell Mol Biol (Noisy-le-grand). 1992 Aug-Sep; 38(5-6):533-43.
    View in: PubMed
    Score: 0.024
  16. Characterization of T lymphocyte clones isolated from BCNU-cured LSA mice. Int J Cell Cloning. 1991 Nov; 9(6):594-605.
    View in: PubMed
    Score: 0.022
  17. Immunosuppression by aldicarb of T cell responses to antigen-specific and polyclonal stimuli results from defective IL-1 production by the macrophages. Toxicol Appl Pharmacol. 1990 Dec; 106(3):408-17.
    View in: PubMed
    Score: 0.021
  18. Characterization of tumor-infiltrating CD4+ T cells as Th1 cells based on lymphokine secretion and functional properties. J Immunol. 1990 Jun 15; 144(12):4898-905.
    View in: PubMed
    Score: 0.020
  19. Evidence for the involvement of CD44 in endothelial cell injury and induction of vascular leak syndrome by IL-2. J Immunol. 1999 Aug 01; 163(3):1619-27.
    View in: PubMed
    Score: 0.010
  20. Evidence for the involvement of Fas ligand and perforin in the induction of vascular leak syndrome. J Immunol. 1998 Sep 15; 161(6):3077-86.
    View in: PubMed
    Score: 0.009
  21. CD4-CD8- thymocytes from MRL-lpr/lpr mice exhibit abnormal proportions of alpha beta- and gamma delta-TCR+ cells and demonstrate defective responsiveness when activated through the TCR. Cell Immunol. 1991 Oct 15; 137(2):269-82.
    View in: PubMed
    Score: 0.006
  22. Autoreactive T cell clones isolated from normal and autoimmune-susceptible mice exhibit lymphokine secretory and functional properties of both Th1 and Th2 cells. Clin Immunol Immunopathol. 1990 Oct; 57(1):148-62.
    View in: PubMed
    Score: 0.005
  23. Evidence for the existence of distinct heterogeneity among the peripheral CD4-CD8- T cells from MRL-lpr/lpr mice based on the expression of the J11d marker, activation requirements, and functional properties. Cell Immunol. 1990 May; 127(2):442-57.
    View in: PubMed
    Score: 0.005
  24. Impaired autoreactive T cell-induced T cell-T cell interaction in aged mice. Cell Immunol. 1988 Oct 15; 116(2):299-307.
    View in: PubMed
    Score: 0.005
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.